Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "HealthEquity"


9 mentions found


Here are Tuesday's biggest calls on Wall Street: Oppenheimer reiterates Nvidia as outperform Oppenheimer said it's sticking with its outperform rating on shares of Nvidia. Citi reiterates Eli Lilly as buy Citi said the biopharma company is "riding the GLP-1 rocket." Citi downgrades Clorox to neutral from buy Citi said that the bullish thesis for the stock has largely played out for now. Citi upgrades Estee Lauder to buy from neutral Citi said it sees a "topline inflection point" for the stock. Barclays upgrades Array Technologies to overweight from equal weight Barclays said it sees share gains for the solar company.
Persons: Oppenheimer, McCormick, Argus, Needham, it's, Nelson Peltz, Melius, Horton, Citi, Eli Lilly, Estee Lauder, ARRY, JMP, Piper Sandler, Piper, Nio, CFRA, Goldman Sachs, Goldman, Blackstone, Petco Organizations: Nvidia, JPMorgan, Disney, Boeing, Citi, Coca, MTH, RBC, GE Vernova, General Electric, Bank of America, Meta, Travel, Barclays, Eaton, MI, Olema Pharmaceuticals, UBS, Bank of, of America Locations: underperform, LEN, DHI, Asia, Eaton, 4Q23
Investors will listen for the central bank's latest perspective on interest rates following the hotter-than-expected CPI and PPI reports this week. As members know, the market is looking for any signs of further disinflation in the housing market as shelter cost inflation remains the Fed's biggest concern. No club names report earnings next week, but we can't wait to see what Nvidia has to show us at its GTC AI developer conference . Other key reports include KB Home on Wednesday, which will provide a real-time look at the state the housing market, unlike the backward-looking housing reports. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Persons: we'll, That's, Jerome Powell's, We're, Jensen, Jim Cramer, Huang, He'll, Lululemon, General Mills, OLLI, LULU, Jim Cramer's, Jim, Jerome Powell, Leah Millis Organizations: Dow, Nasdaq, PPI, Nvidia, Blackwell, CNBC, Micron Technology, Citi, Micron, Broadcom, Nike, FedEx, Music Entertainment, ZTO, Signet Jewelers, SIG, Sportradar, Micron Tech, KB, Worthington Industries, Accenture, Darden, Academy Sports &, Lufax, Brands, Winnebago Industries, Commercial Metals Company, Jim Cramer's Charitable, U.S . Federal, Federal, Market Locations: U.S, California, China, Washington , U.S
Interest rates keep climbing, but that's not stopping Wall Street analysts from finding a slew of stocks to buy. CNBC Pro combed through top Wall Street research to find stocks that are beneficiaries of high interest rates. HealthEquity "We view HQY as an attractive investment in a higher interest rate environment that can function as a portfolio diversifier," according to Baird analyst Mark Marcon. The firm said as middle market businesses face rising interest rates, Bunge can take advantage. Toll Brothers High interest rates are no problem for the homebuilder, Raymond James analyst Buck Horne said in a recent note.
Persons: Bunge, Baird, Mark Marcon, Marcon, Goldman Sachs, Adam Samuelson, Samuelson, Raymond James, Buck Horne, Horne, homebuilders, TOL, HealthEquity, Morgan Stanley Organizations: CNBC, Bank of America, Toll, HealthEquity, Costco, Evercore ISI, CMA, Catering Locations: HealthEquity, homebuilders, homebuilding
Here are Thursday's biggest calls on Wall Street: Baird reiterates Meta as outperform Baird said it's bullish heading into Meta's Connect event next week. Bank of America upgrades Nutanix to buy from neutral Bank of America said it sees numerous positive growth drivers ahead for the computer software company. " Guggenheim reiterates Sunrun as buy Guggenheim said Sunrun is the best positioned solar company. Bank of America reiterates Marriott as buy Bank of America said it's bullish heading into Marriott's analyst day next week. Wells Fargo reiterates Amazon as overweight Wells said it sees several "discreet headwinds" for Amazon that investors may not know about.
Persons: Baird, it's, NTNX, Guggenheim, Sunrun, Evercore, Goldman Sachs, Goldman, Jefferies, Wedbush, Uber, JPMorgan, rideshare, Piper Sandler, Piper, Marriott, Wolfe, Wells, Morgan Stanley, Howmet, Truist Organizations: Meta's, Meta, Qualcomm, Bank of America, of America, Costco, Google, JPMorgan, Disney, Petrobras, CF, Microsoft, monetization, UBS, Walmart, Deutsche Bank, Wax Center, Exxon, ExxonMobil, " Bank of America, Citi, Energy, Micron, MU, Aerospace Locations: Howmet's Whitehall
Final Trades: HealthEquity, AT&T, EQT & more
  + stars: | 2023-06-07 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trades: HealthEquity, AT&T, EQT & moreThe "Halftime Report" traders give their top picks to watch for the second half.
Here are the stocks making the biggest moves in midday trading Tuesday, June 6. Coinbase — Shares of the crypto exchange fell 12% after the U.S. Securities and Exchange Commission sued Coinbase on Tuesday. GitLab reported a 6-cent loss per share, better than the 14-cent loss per share the consensus anticipated, according to Refinitiv. Thor reported earnings of $2.24 per diluted share, while analysts surveyed by FactSet were expecting $1.07 per share. HealthEquity — The stock added about 11.6% the day after the company beat expectations on earnings and gave positive full-year guidance.
Persons: Coinbase, GitLab, Refinitiv, Thor, FactSet, Zions Bancorporation, KeyCorp, McCormick, Smucker, , Alex Harring, Yun Li, Samantha Subin Organizations: U.S . Securities, Exchange Commission, SEC, Industries, Thor Industries, Comerica, KeyCorp, Regional Bank ETF, Bank of America, VF Corp, Locations: KeyCorp —, California
UBS agreed to buy its longtime rival Credit Suisse for $3 billion on Sunday. There's one big winner — and lots of losers — from the Credit Suisse rescue deal. The deal announced Sunday afternoon valued Credit Suisse shares at just 0.76 Swiss francs, one-fifth of the price the Saudi National Bank paid. Lastly, the merger between UBS and Credit Suisse could be bad news for the Fed. Here's how the Credit Suisse rescue deal impacts the central bank.
Jefferies reiterated HealthEquity as a buy on Wednesday, noting the company's favorable position in the health savings account market. Analyst Glen Santangelo placed a price target of $84 on the stock, suggesting shares stand to gain nearly 29% from Wednesday's close. HealthEquity shares gained 39% in 2022, but the stock is only up about 6% year to date. Although the stock has "seemingly fallen off investor's radar screens," Santangelo noted that the company is highly favored in the HSA market. "Most importantly, we believe that current consensus estimates underappreciate the impact of higher rates in [fiscal 2025 (calendar year 2024)].
Cramer's lightning round: I'm very concerned about Veru
  + stars: | 2023-01-06 | by ( Krystal Hur | ) www.cnbc.com   time to read: +1 min
Loading chart...Veru Inc : "I'm very concerned about it." I think we're going to have to take a major league pass." Suburban Propane Partners LP : "[The] propane market is historically, let's say, too volatile and erratic for me." Loading chart...Axon Enterprise Inc : "It's a terrific law enforcement package that I think is really good for everybody. Loading chart...Nuscale Power Corp : "If you want small, nuclear modular reactors, I'm going to have to say, the Constellation Energy group.
Total: 9